Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors

References

• Cao W, Lu X, Cheng Z. The advancement of human serum albumin-based molecular probes for molecular imaging. Curr Pharm Des. 2015;21(14):1908–1915.25732549
   PubMed Web of Science ®Google Scholar
• Lee P, Wu X. Review: modifications of human serum albumin and their binding effect. Curr Pharm Des. 2015;21(14):1862–1865.25732553
   PubMed Web of Science ®Google Scholar
• Sleep D, Cameron J, Evans LR. Albumin as a versatile platform for drug half-life extension. Biochim Biophys Acta. 2013;1830(12):5526–5534. doi:10.1016/j.bbagen.2013.04.02323639804
   PubMed Web of Science ®Google Scholar
• Chuang VT, Kragh-Hansen U, Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res. 2002;19(5):569–577.12069157
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76(1):333–337.218198
   PubMed Web of Science ®Google Scholar
• Gustafsson B, Hedin U, Caidahl K. Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes. Contrast Media Mol Imaging. 2015;10(1):37–42. doi:10.1002/cmmi.159824753457
   PubMedGoogle Scholar
• Gustafsson B, Youens S, Louie AY. Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. Bioconjug Chem. 2006;17(2):538–547. doi:10.1021/bc060018k16536488
   PubMedGoogle Scholar
• Haberland ME, Fogelman AM. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages. Proc Natl Acad Sci U S A. 1985;82(9):2693–2697.3857610
   PubMed Web of Science ®Google Scholar
• Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988;241(4862):215–218.2455346
   PubMed Web of Science ®Google Scholar
• Haberland ME, Rasmussen RR, Fogelman AM. Receptor recognition of maleyl-albumin induces chemotaxis in human monocytes. J Clin Invest. 1986;78(3):827–831. doi:10.1172/JCI1126473018045
   PubMedGoogle Scholar
• Haberland ME, Rasmussen RR, Olch CL, Fogelman AM. Two distinct receptors account for recognition of maleyl-albumin in human monocytes during differentiation in vitro. J Clin Invest. 1986;77(3):681–689. doi:10.1172/JCI1123623949974
   PubMedGoogle Scholar
• Hamblin MR, Miller JL, Ortel B. Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol. 2000;72(4):533–540.11045726
   PubMed Web of Science ®Google Scholar
• Jarrett BR, Correa C, Ma KL, Louie AY. In vivo mapping of vascular inflammation using multimodal imaging. PLoS One. 2010;5(10):e13254. doi:10.1371/journal.pone.001325420949008
   PubMed Web of Science ®Google Scholar
• Kelley JL, Ozment TR, Li C, Schweitzer JB, Williams DL. Scavenger receptor-A (CD204): a two-edged sword in health and disease. Crit Rev Immunol. 2014;34(3):241–261.24941076
   PubMed Web of Science ®Google Scholar
• Libby P. Assisted living in the atheroma: elderly macrophages promote plaques. Cell Metab. 2016;24(6):779–781. doi:10.1016/j.cmet.2016.11.01327974178
   PubMedGoogle Scholar
• Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54(1):24–38. doi:10.1373/clinchem.2007.09736018160725
   PubMed Web of Science ®Google Scholar
• Platt N, Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse’s tale. J Clin Invest. 2001;108(5):649–654. doi:10.1172/JCI1390311544267
   PubMedGoogle Scholar
• de Winther MP, van Dijk KW, Havekes LM, Hofker MH. Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20(2):290–297.10669623
   PubMed Web of Science ®Google Scholar
• Canton J, Neculai D, Grinstein S. Scavenger receptors in homeostasis and immunity. Nat Rev Immunol. 2013;13(9):621–634. doi:10.1038/nri351523928573
   PubMed Web of Science ®Google Scholar
• Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997;8(5):275–280.9335951
   PubMed Web of Science ®Google Scholar
• Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis. 2005;182(1):1–15. doi:10.1016/j.atherosclerosis.2005.03.03615904923
   PubMed Web of Science ®Google Scholar
• Prabhudas M, Bowdish D, Drickamer K, et al. Standardizing scavenger receptor nomenclature. J Immunol. 2014;192(5):1997–2006. doi:10.4049/jimmunol.149000324563502
   PubMed Web of Science ®Google Scholar
• PrabhuDas MR, Baldwin CL, Bollyky PL, et al. A consensus definitive classification of scavenger receptors and their roles in health and disease. J Immunol. 2017;198(10):3775–3789. doi:10.4049/jimmunol.170037328483986
   PubMed Web of Science ®Google Scholar
• Bieghs V, Verheyen F, van Gorp PJ, et al. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PLoS One. 2012;7(3):e34378. doi:10.1371/journal.pone.003437822470565
   PubMed Web of Science ®Google Scholar
• Hughes DA, Fraser IP, Gordon S. Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol. 1995;25(2):466–473. doi:10.1002/eji.18302502247875210
   PubMed Web of Science ®Google Scholar
• Ben J, Zhu X, Zhang H, Chen Q. Class A1 scavenger receptors in cardiovascular diseases. Br J Pharmacol. 2015;172(23):5523–5530. doi:10.1111/bph.1310525651870
   PubMed Web of Science ®Google Scholar
• Zani IA, Stephen SL, Mughal NA, et al. Scavenger receptor structure and function in health and disease. Cells. 2015;4(2):178–201. doi:10.3390/cells402017826010753
   PubMed Web of Science ®Google Scholar
• Gough PJ, Gordon S. The role of scavenger receptors in the innate immune system. Microbes Infect. 2000;2(3):305–311.10758407
   PubMed Web of Science ®Google Scholar
• Platt N, Haworth R, Darley L, Gordon S. The many roles of the class A macrophage scavenger receptor. Int Rev Cytol. 2002;212:1–40.11804035
   PubMedGoogle Scholar
• Pluddemann A, Neyen C, Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods. 2007;43(3):207–217. doi:10.1016/j.ymeth.2007.06.00417920517
   PubMedGoogle Scholar
• Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol. 2001;12(5):489–495.11561167
   PubMed Web of Science ®Google Scholar
• Nakata A, Nakagawa Y, Nishida M, et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol. 1999;19(5):1333–1339.10323787
   PubMed Web of Science ®Google Scholar
• Mietus-Snyder M, Gowri MS, Pitas RE. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J Biol Chem. 2000;275(23):17661–17670.10837497
   PubMedGoogle Scholar
• Loboda A, Jazwa A, Jozkowicz A, Molema G, Dulak J. Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vascul Pharmacol. 2006;44(4):206–214. doi:10.1016/j.vph.2005.11.00716481221
   PubMedGoogle Scholar
• Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 2006;26(8):1702–1711. doi:10.1161/01.ATV.0000229218.97976.4316728653
   PubMed Web of Science ®Google Scholar
• Vosjan M, Perk LR, Visser GWM, et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat Protoc. 2010;5(4):739–743. doi:10.1038/nprot.2010.1320360768
   PubMedGoogle Scholar
• Laguna-Fernandez A, Checa A, Carracedo M, et al. ERV1/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages. Circulation. 2018;138(16):1693–1705. doi:10.1161/CIRCULATION-AHA.117.03280129739755
   PubMedGoogle Scholar
• Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest. 1998;101(8):1717–1725. doi:10.1172/JCI12169541503
   PubMedGoogle Scholar
• Chellan B, Reardon CA, Getz GS, Hofmann Bowman MA. Enzymatically modified low-density lipoprotein promotes foam cell formation in smooth muscle cells via macropinocytosis and enhances receptor-mediated uptake of oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2016;36(6):1101–1113. doi:10.1161/ATVBAHA.116.30730627079883
   PubMedGoogle Scholar
• Richter E, Ventz K, Harms M, Mostertz J, Hochgrafe F. Induction of macrophage function in human THP-1 cells is associated with rewiring of MAPK signaling and activation of MAP3K7 (TAK1) protein kinase. Front Cell Dev Biol. 2016;4:21. doi:10.3389/fcell.2016.0002127066479
   PubMed Web of Science ®Google Scholar
• Forteza MJ, Polyzos KA, Baumgartner R, et al. Activation of the regulatory T-Cell/Indoleamine 2,3-dioxygenase axis reduces vascular inflammation and atherosclerosis in hyperlipidemic mice. Front Immunol. 2018;9:950. doi:10.3389/fimmu.2018.0095029867939
   PubMedGoogle Scholar
• Matic LP, Jesus Iglesias M, Vesterlund M, et al. Novel multiomics profiling of human carotid atherosclerotic plaques and plasma reveals biliverdin reductase B as a marker of intraplaque hemorrhage. JACC Basic Transl Sci. 2018;3(4):464–480. doi:10.1016/j.jacbts.2018.04.00130175270
   PubMedGoogle Scholar
•  Ahmed M, Gustafsson B, Aldi S, et al. Molecular imaging of a new multimodal microbubble for adhesion molecule targeting. Cel Mol Bioeng. 2019;12(1):15–32. 
   Google Scholar
• Ling W, Lougheed M, Suzuki H, Buchan A, Kodama T, Steinbrecher UP. Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene. J Clin Invest. 1997;100(2):244–252. doi:10.1172/JCI1195289218499
   PubMedGoogle Scholar
• Takata K, Horiuchi S, Morino Y. Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation. Biochim Biophys Acta. 1989;984(3):273–280.2775777
   PubMedGoogle Scholar
• Ahmed N, Dobler D, Dean M, Thornalley PJ. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem. 2005;280(7):5724–5732. doi:10.1074/jbc.M41097320015557329
   PubMedGoogle Scholar
• Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci U S A. 1982;79(6):1712–1716.6281781
   PubMed Web of Science ®Google Scholar
• Warnecke A, Abele S, Musunuri S, Bergquist J, Harris RA. Scavenger receptor a mediates the clearance and immunological screening of MDA-modified antigen by M2-type macrophages. Neuromolecular Med. 2017;19(4):463–479. doi:10.1007/s12017-017-8461-y28828577
   PubMedGoogle Scholar
• Miki Y, Koyama K, Kurusu H, Hirano K, Beppu M, Fujiwara Y. Nucleolin is a receptor for maleylated-bovine serum albumin on macrophages. Biol Pharm Bull. 2015;38(1):116–121. doi:10.1248/bpb.b14-0062425744467
   PubMedGoogle Scholar
• Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118(4):653–667. doi:10.1161/CIRCRESAHA.115.30625626892964
   PubMed Web of Science ®Google Scholar
• Ingersoll MA, Spanbroek R, Lottaz C, et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood. 2010;115(3):e10–19. doi:10.1182/blood-2009-07-23502819965649
   PubMed Web of Science ®Google Scholar
• Allahverdian S, Francis GA. Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells. Trends Cardiovasc Med. 2010;20(3):96–102. doi:10.1016/j.tcm.2010.09.00221130953
   PubMedGoogle Scholar
• Chaabane C, Coen M, Bochaton-Piallat ML. Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr Opin Lipidol. 2014;25(5):374–379. doi:10.1097/MOL.000000000000011325110900
   PubMed Web of Science ®Google Scholar
• Pidkovka NA, Cherepanova OA, Yoshida T, et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res. 2007;101(8):792–801. doi:10.1161/CIRCRESAHA.107.15273617704209
   PubMedGoogle Scholar
• Robbins CS, Hilgendorf I, Weber GF, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19(9):1166–1172. doi:10.1038/nm.325823933982
   PubMed Web of Science ®Google Scholar
• Jaffer FA, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol. 2006;47(7):1328–1338. doi:10.1016/j.jacc.2006.01.02916580517
   PubMedGoogle Scholar
• Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med. 2008;5(Suppl 2):S2–10. doi:10.1038/ncpcardio124718641603
   PubMedGoogle Scholar
• Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15(6):439–446.12476646
   PubMedGoogle Scholar
• Fischer G, Seibold U, Schirrmacher R, Wangler B, Wangler C. (89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges. Molecules. 2013;18(6):6469–6490. doi:10.3390/molecules1806646923736785
   PubMed Web of Science ®Google Scholar
• Jauw YW, Menke-van der Houven van Oordt CW, Hoekstra OS, et al. Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: what can we learn from initial clinical trials? Front Pharmacol. 2016;7:131. doi:10.3389/fphar.2016.0032327252651
   PubMedGoogle Scholar
• Majmudar MD, Yoo J, Keliher EJ, et al. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res. 2013;112(5):755–761. doi:10.1161/CIRCRESAHA.111.30057623300273
   PubMed Web of Science ®Google Scholar
• Perez-Medina C, Binderup T, Lobatto ME, et al. In vivo PET imaging of HDL in multiple atherosclerosis models. JACC Cardiovasc Imaging. 2016;9(8):950–961. doi:10.1016/j.jcmg.2016.01.02027236528
   PubMedGoogle Scholar
• Senders ML, Que X, Cho YS, et al. PET/MR imaging of malondialdehyde-acetaldehyde epitopes with a human antibody detects clinically relevant atherothrombosis. J Am Coll Cardiol. 2018;71(3):321–335. doi:10.1016/j.jacc.2017.11.03629348025
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hong H, Cai W. PET tracers based on Zirconium-89. Curr Radiopharm. 2011;4(2):131–139.22191652
   PubMedGoogle Scholar